Building on the Global Action Plan on Antimicrobial Resistance, the overall purpose of the proposed new roadmap on antimicrobial resistance for the WHO European Region 2023–2030 is to support countries to identify, prioritize, implement and monitor high-impact interventions to tackle antimicrobial resistance (AMR). The roadmap sets the direction of travel until 2030 and reflects innovations in AMR, including a greater focus on the environmental and social determinants, digital transformation and people centredness. Its implementation is crucial not only to AMR but also to achieving universal health coverage, working towards the Sustainable Development Goals, strengthening primary health care and ensuring adequate pandemic preparedness and response. The roadmap is organized around an AMR Compass that identifies five action areas and six enablers based on a combination of the best available evidence and expert opinion, for countries to adapt to their own national contexts. Each action area and enabler has a set of high-impact interventions and is intended as a practical and adaptable tool for countries to convene all relevant national AMR
stakeholders, reach consensus on their priorities and inform the investment cases for action on AMR. This working document, together with a supporting information document, and a draft decision are submitted to the WHO Regional Committee for Europe for endorsement at its 73rd session in October 2023.